Denali Therapeutics DNLI 深 滬
已收盤 12-24 16:00:00 美东时间
16.99
+0.180
+1.07%
華盛通- 最 高17.045
- 今 開16.90
- 成交量 50.50万股
- 最 低 16.72
- 昨 收 16.81
- 總市值 24.98亿
- 52周最高 24.345
- 市盈率 靜 --
- 換手率 0.34%
- 52周最低 10.57
- 委 比 99.38%
- 總股本 1.47亿
- 歷史最高 93.94
- 量 比 0.37
- 振 幅 1.93%
- 歷史最低 10.57
- 每 手 1
- 風險率 2.88%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 绩后分化！甲骨文遭14家大行集体下调目标价；新思科技、Planet获多家机构上调目标价！
今日重点评级关注：HC Wainwright & Co.：维持Moleculin Biotech"买入"评级，目标价从4美元升至22美元；HC Wainwright & Co.：上调Soluna Holdings评级至"买入"，目标价5美元
12-12 10:24
Wedbush Maintains Outperform on Denali Therapeutics, Lowers Price Target to $30
Wedbush analyst Laura Chico maintains Denali Therapeutics (NASDAQ:DNLI) with a Outperform and lowers the price target from $31 to $30.
12-11 22:31
Denali Therapeutics Announces $200M Public Offering
Denali Therapeutics ( ($DNLI) ) has shared an update. On December 9, 2025, Dena...
12-11 06:49
Denali Therapeutics dips after pricing $200M equity offering
Denali Therapeutics priced its public offering of 9.14M shares at $17.50 each, plus pre-funded warrants to purchase around 2.29M shares at $17.49 per pre-funded warrant. Click here to read more. More ...
12-10 18:34
美股大行评级 | 高盛上调梅西百货目标价至22美元！ 摩根大通上调美国铝业公司目标价至45美元
今日重点评级关注：Stifel：维持X4 Pharmaceuticals"买入"评级，目标价从7.5美元升至10美元；花旗：维持UP Fintech Holding"买入"评级，目标价从17.4美元升至17.5美元
12-08 08:34
Denali Therapeutics And Royalty Pharma Announce $275M Synthetic Royalty Funding Agreement Based On Future Net Sales Of Tividenofusp Alfa
Denali Therapeutics Inc. (NASDAQ:DNLI) and Royalty Pharma plc (NASDAQ:RPRX) today announced a $275 million synthetic royalty funding agreement based on future net sales of tividenofusp alfa.Tividenofusp alfa is Denali's
12-04 20:05
Catalyst Watch: Holiday shopping data, Amazon event, and Salesforce earnings
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. Monday - December ...
11-29 02:30
美股大行评级 | 最高255美元！9家大行集体上调Palantir目标价；Axsome、Exact、Fabrinet、ZoomInfo、爱德士、MongoDB、安森美半导体等也获多家大行上调目标价
今日重点评级关注：瑞银：维持Syndax Pharmaceuticals"买入"评级，目标价从35美元升至38美元；HC Wainwright & Co.：维持Benitec Biopharma"买入"评级，目标价从28美元升至35美元
11-05 10:35
JP Morgan Maintains Overweight on Denali Therapeutics, Raises Price Target to $26
JP Morgan analyst Jessica Fye maintains Denali Therapeutics (NASDAQ:DNLI) with a Overweight and raises the price target from $24 to $26.
11-04 23:00
Denali Therapeutics Faces FDA Review Extension
Denali Therapeutics ( ($DNLI) ) has shared an update. On October 13, 2025, Dena...
10-14 20:28
